Treatment Persistence In Psoriasis Patients Initiated on Apremilast, Oral Systemics, or Biologic Therapies
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2397
https://www.valueinhealthjournal.com/article/S1098-3015(17)32731-6/fulltext
Title :
Treatment Persistence In Psoriasis Patients Initiated on Apremilast, Oral Systemics, or Biologic Therapies
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32731-6&doi=10.1016/j.jval.2017.08.2397
First page :
A805
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2218